PROVIDER PROFILE · NPI 1801011465

Brian BakofenDO

PRACTICEFENWAY HEALTHSee all providers at this practice →

Internal MedicineBoston, MAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,355

Beneficiaries

—

Total drug cost

$759K

Distinct drugs

Brand share

21.3%

Top prescribed drugs

Rosuvastatin Calcium127 claims

Bictegrav/Emtricit/Tenofov Ala112 claims

Oxycodone Hcl80 claims

Lisinopril66 claims

Atorvastatin Calcium61 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Brian Bakofen's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
FENWAY COMMUNITY HEALTH CENTER, INC	86	491
Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA	56	161
Alex Gonzalez Internal Medicine · Boston, MA	14	18

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history